Goldline Pharmaceutical IPO Details
The Goldline Pharmaceutical IPO has a lot size of 3,000 shares. Retail investors require a minimum investment of ₹2,58,000 by applying for 2 lot (6,000 shares). The maximum application allowed for the retail category is 2 lots (6,000 shares), requiring an investment of ₹2,58,000.
For Small Non-Institutional Investors (S-HNI), the minimum application is 3 lots (9000 shares) with an investment of ₹3,87,000. while the maximum application is 7 lots (21000 shares) amounting to ₹9,03,000..
For Big Non-Institutional Investors (B-HNI), the minimum application size is 8 lots (24000 shares), requiring an investment of ₹10,32,000.
Goldline Pharmaceutical IPO Investment Details
- IPO Lot Size: 3,000 Shares
- Minimum Retail Investment: ₹2,58,000.
- Maximum Retail Investment: ₹2,58,000 (2 Lots)
- Minimum S-HNI Investment: ₹3,87,000 (3 Lots)
- Maximum S-HNI Investment: ₹9,03,000 (7 Lots)
- Minimum B-HNI Investment: ₹10,32,000 (8 Lots)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Goldline Pharmaceutical IPO Lot Size
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 6,000 | 258,000.00 |
| Retail (Max) | 2 | 6,000 | 258,000.00 |
| S-HNI (Min) | 3 | 9,000 | 387,000.00 |
| S-HNI (Max) | 7 | 21,000 | 903,000.00 |
| B-HNI (Min) | 8 | 24,000 | 1,032,000.00 |
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is Goldline Pharmaceutical IPO Lot Size?
Goldline Pharmaceutical IPO lot size is 3000 shares. Retail investors need a minimum investment of ₹258000 based on the upper price band of ₹43 per share.
When Will the Goldline Pharmaceutical IPO be Listed?
Goldline Pharmaceutical IPO was listed on the BSE on Tue, May 19, 2026.
What is the minimum investment required for the Goldline Pharmaceutical IPO?
The minimum investment required for the Goldline Pharmaceutical IPO is ₹258000. This amount is based on applying for two lots of 3000 shares at the upper price band of ₹43 per share.
What is the maximum investment allowed for retail investors in the Goldline Pharmaceutical IPO?
Retail investors can apply for a maximum of 2 lots, equivalent to 6000 shares, requiring an investment of ₹258000.
What is the minimum investment for HNI investors in the Goldline Pharmaceutical IPO?
For the Goldline Pharmaceutical IPO,the minimum investment for Small HNI (S-HNI) investors is ₹387000, which corresponds to 3 lots (9000 shares). Big HNI (B-HNI) investors must apply for a minimum of 8 lots (24000 shares), requiring an investment of ₹1032000 at the upper price band of ₹43 per share.